Fellay, JacquesMarzolini, CatiaMeaden, Emma R.Back, David J.Buclin, ThierryChave, Jean PhilippeDecosterd, Laurent A.Furrer, HansjakobOpravil, MilosPantaleo, GiuseppeRetelska, DorotaRuiz, LidiaSchinkel, Alfred H.Vernazza, PietroEap, Chin B.Telenti, Amalio2011-04-152011-04-152011-04-15200210.1016/S0140-6736(02)07276-8https://infoscience.epfl.ch/handle/20.500.14299/66458HIV-1-infected patients vary considerably by their response to antiretroviral treatment, drug concentrations in plasma, toxic events, and rate of immune recovery. This variability could have a genetic basis. We did a pharmacogenetics study to analyse the association between response to antiretroviral treatment and allelic variants of several genes.HIV-1Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics studytext::journal::journal article::research article